Target intelligence / Profile preview

ribosomal protein L10 pseudogene 7 (RPL10P7)

Target
RPL10P7
Molecular classification
Other, Processed pseudogene, Ribosomal protein pseudogene
01

Overview

RPL10P7 is a processed pseudogene, meaning it originated from retrotransposition of mRNA from a functional ribosomal protein L10 gene (RPL10), but has lost its protein-coding ability and is generally not transcribed or translated into a functional protein[2][3][4]. The RPL10 gene encodes a structural protein in the large 60S subunit of ribosomes, important for protein synthesis[1][5]. However, RPL10P7 and similar pseudogenes are non-functional genomic relics without known physiological or pathological significance[2][4]. Multiple RPL10 pseudogenes exist in the human genome, but only the original (RPL10) and certain paralogs (like RPL10L) encode active proteins with biological functions[3][4][6]. No evidence supports RPL10P7 as a drug target, disease-related biomarker, or functional participant in cellular processes. If the query intended a functional protein target (such as RPL10 or RPL10L), those have specific roles in ribosome structure and function, but RPL10P7 does not. The naming similarity often causes confusion, so attention is required to select the correct gene/protein in research or therapeutic contexts.

Other names
RPL10_2_395RPL10P7
02

Mechanism of action

None (no drug mechanism as not a target)

Beyond the preview

Go deeper on ribosomal protein L10 pseudogene 7 (RPL10P7).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ribosomal protein L10 pseudogene 7 (RPL10P7).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call